Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasopressor Outcomes in Spine Surgery
NCT06053398Phase 1Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Nov 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of norepinephrine in hypotension (2 arms), sponsored by UT Southwestern Medical Center. Primary endpoint: Vasopressor requirement. Started Nov 2023; status: completed.
02
Drugs
norepinephrine
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT06053398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06053398.